By Julia Cipriano, MS  / November 2024  / 2024 NCCN Annual Congress: Hematologic Malignancies

Determining the Optimal First-Line Management of Advanced Classical Hodgkin Lymphoma

“While clinical trials emphasize improvement in cure rates for patients with advanced classical Hodgkin lymphoma, an important goal is reducing the potential long-term effects of treatment,” commente...